Knowledge Leaders Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,316
Closed -$1.03M 84
2023
Q2
$1.03M Sell
13,316
-414
-3% -$33K 1.18% 19
2023
Q1
$1.14M Sell
13,730
-414
-3% -$34.3K 1.51% 15
2022
Q4
$1.21M Buy
14,144
+8,079
+133% +$640K 1.6% 13
2022
Q3
$374K Sell
6,065
-336
-5% -$21.2K 0.48% 84
2022
Q2
$396K Sell
6,401
-667
-9% -$41.3K 0.38% 85
2022
Q1
$420K Hold
7,068
0.3% 102
2021
Q4
$513K Buy
7,068
+684
+11% +$47.1K 0.38% 98
2021
Q3
$446K Buy
6,384
+76
+1% +$5.34K 0.36% 95
2021
Q2
$434K Buy
6,308
+76
+1% +$5.08K 0.29% 117
2021
Q1
$403K Hold
6,232
0.32% 104
2020
Q4
$363K Hold
6,232
0.32% 94
2020
Q3
$394K Hold
6,232
0.37% 90
2020
Q2
$479K Buy
+6,232
New +$478K 0.48% 79

Other funds holding GILD

Knowledge Leaders Capital's GILD Position: Q3 2023 in Review

Knowledge Leaders Capital sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 13,316 shares — an estimated $1.03M sold.

Knowledge Leaders Capital first reported a position in GILD in Q2 2020 and held it in 13 quarters. The position peaked at $1.21M in Q4 2022. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Knowledge Leaders Capital reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Knowledge Leaders Capital sold 13,316 Gilead Sciences shares in Q3 2023, an estimated $1.03M.
  • Knowledge Leaders Capital first reported a position in Gilead Sciences in Q2 2020 and held it in 13 quarters.
  • Knowledge Leaders Capital's Gilead Sciences position peaked at $1.21M in Q4 2022.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Knowledge Leaders Capital's 13F filing for Q3 2023, filed 7 Nov 2023.